Electrophoresis Market

The global Electrophoresis Market size in terms of revenue was USD 3.1 Billion in 2023 and is projected to reach USD 4.1 Billion by 2028, expanding at a CAGR of 5.7% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. The growth in this market is attributed to the the growing industry-academia research collaboations, and increasing number of clinical, forensic and research labs screening will drive the growth of the market. On the other hand, safety concerns associated with electrophoresis reagents may challenge the growth of market. Whereas, increasing demand for personalized medicines to provide growth opportunities for market.

Attractive Opportunities in the Electrophoresis Market

To know about the assumptions considered for the study, Request for Free Sample Report

Global Electrophoresis Dynamics

DRIVER: Growing industry-academia research collaborations

Electrophoresis is used in proteomic and genomic research in academic and research institutes. It is also used in the diagnosis of diseases and the quality control of drugs in pharmaceutical and biotechnology companies. Due to the widespread applications of electrophoresis, market players are collaborating with various academic institutions to increase awareness about new analytical technologies among students and researchers. For instance, In August 2022, SciGenom Labs, a genomics company in India and the US, announced a unique Ph.D. program to support research in genomics, proteomics, microbiome disciplines, and bio-nanotech in collaboration with CHARUSAT University. Numerous collaborative research projects and similar initiatives have already been launched, and several others are expected to be initiated during the forecast period. Several companies are also helping university researchers by providing technical and financial assistance to commercialize university research projects. Such developments are expected to positively impact the growth of the market during the forecast period.

OPPORTUNITY: Increasing demand for personalized medicines

Personalized medicine, which has become a core area of research in the healthcare industry, has entered mainstream clinical practice and is changing how many diseases are identified, classified, and treated. These advancements are particularly evident in the area of oncology. This growing demand for personalized medicine is expected to increase the uptake of electrophoretic systems in the drug development process. For instance:

• In October 2021, 4baseCare (India), a precision oncology company, collaborated with Cellworks Group, Inc. (US), a leading company in personalized medicine for oncology and immunology. The collaboration aimed to deliver greater insights to the oncology fraternity, predict patient therapy responses and enable therapy selection resulting in optimal treatment outcomes.
• In October 2021, 11 multidisciplinary projects in Israel, including research on cancers, Crohn’s, and rare diseases, received NIS 32 million (USD 9.9 million) in grants from Israel Precision Medicine Partnership to help accelerate the pace of discovery and the potential for implementing new therapeutic approaches and position Israel at the forefront of global precision medicine research

CHALLENGE: Need for high procedural efficiency to ensure accurate results

Electrophoresis requires a complex combination of analytical knowledge, extensive manual handling, dexterity, and strict protocol adherence to achieve reliable results. Furthermore, the gel concentration must be accurate to avoid errors; if too high or too low, the fragments will migrate too slowly or quickly, leading to errors in resolving the different bands. Care must be taken during the electrophoresis run to ensure the voltage is steady. Any fluctuations in the voltage will result in the unsteady migration of DNA fragments, leading to errors in reading the bands. The buffer solution must also be of the correct composition, as a buffer with the wrong pH or ionic concentration will change the DNA fragment shape and migration times.

Electrophoresis Market Ecosystem

Prominent companies in this market include well-established, financially stable manufacturers of electrophoresis systems, reagent, gel documentation systems and software. These companies have been operating in the market for several years and possess a diversified product portfolio, state-of-the-art technologies, and strong global sales and marketing networks. Prominent companies in this market include Thermo Fisher Scientific Inc. (US), Bio-Rad Laboratories (US), Merck Group (Germany), Agilent Technologies (US), and Danaher Corporation (US).

In 2022, software segment to observe highest growth rate of the electrophoresis industry, by product

Based on the products, the global electrophoresis market is broadly segmented into electrophoresis reagents, electrophoresis systems, gel documentation systems, and software. Software segment to observe highest growth rate during the forecast period. The high growth rate can be attributed to the simple and user-friendly workflow to guide users through each step of the analysis, allowing effortless identification of significantly changing proteins.

In 2022, academic & research institutes segment to dominate the electrophoresis industry, by end user

Based on end user, the electrophoresis market is segmented into academic & research institutes, hospitals & diagnostic centers, pharmaceutical & biotechnology companies, and other end users. Academic & research institutes to dominate the market due to increasing research being conducted in the fields of drug designing, proteomics, genomics, sequencing, biomarker discovery, and personalized medicine.

In 2022, North America to dominate in electrophoresis industry

The global electrophoresis market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. North America is expected to dominate during the forecast period, primarily due to government initiatives to promote research, the increasing need to combat cancer, as well as growing public-private partnerships to promote research in areas of genomics and proteomics.

To know about the assumptions considered for the study, download the pdf brochure

The electrophoresis market is dominated by players such Thermo Fisher Scientific Inc. (US), Bio-Rad Laboratories (US), Merck Group (Germany), Agilent Technologies (US), and Danaher Corporation (US).

Scope of the Electrophoresis Industry:

This research report categorizes the Electrophoresis market to forecast revenue and analyze trends in each of the following submarkets:

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

By Product

• Electrophoresis Reagents
• Electrophoresis Systems
• Gel Documentation Systems
• Electrophoresis Software

By Application

• Research Applications
• Diagnostics Applications
• Quality Control & Process Validation

By End User

• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies
• Hospitals & Diagnostic Centers
• Other End Users

Recent Developments of Electrophoresis Industry:

• In 2023, Advanced Electrophoresis Solutions Ltd (Canada) signed Medispec (India) as an exclusive distributor partner in India. This will allow AES’ critical solutions to reach many companies located in India.
• In 2022, Thermo Fisher Scientific (US) introduced a new Applied Biosystems SeqStudio Flex Series Genetic Analyzer to enable customers’ cutting-edge research in areas such as gene editing and infectious disease.
• In 2020, Danaher Corporation (US) acquired GE Healthcare Life Sciences (US) and rebranded it as Cytiva. This company will be a $3.3-billion global life sciences company with nearly 7000 employees in 40 countries.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst